Marine Natural Products: A Source of Novel Anticancer Drugs

Shaden A. M. Khalifa(Karolinska University Hospital), Nizar Elias(University of Kalamoon), Mohamed A. Farag(Cairo University), Lei Chen(Fujian Agriculture and Forestry University), Aamer Saeed(Quaid-i-Azam University), Mohamed‐Elamir F. Hegazy(Johannes Gutenberg University Mainz), Moustafa S. Moustafa(Kuwait University), Aida A. Abd El‐Wahed(Kuwait University), Saleh Mohammed Al‐Mousawi(Kuwait University), Syed Ghulam Musharraf(University of Karachi), Fang‐Rong Chang(Kaohsiung Medical University), Arihiro Iwasaki(Keio University), Kiyotake Suenaga(Keio University), Muaaz Alajlani(Uppsala University), Ulf Göransson(Uppsala University), Hesham R. El‐Seedi(Jiangsu University)
Marine Drugs
August 23, 2019
Cited by 550Open Access
Full Text

Abstract

Cancer remains one of the most lethal diseases worldwide. There is an urgent need for new drugs with novel modes of action and thus considerable research has been conducted for new anticancer drugs from natural sources, especially plants, microbes and marine organisms. Marine populations represent reservoirs of novel bioactive metabolites with diverse groups of chemical structures. This review highlights the impact of marine organisms, with particular emphasis on marine plants, algae, bacteria, actinomycetes, fungi, sponges and soft corals. Anti-cancer effects of marine natural products in in vitro and in vivo studies were first introduced; their activity in the prevention of tumor formation and the related compound-induced apoptosis and cytotoxicities were tackled. The possible molecular mechanisms behind the biological effects are also presented. The review highlights the diversity of marine organisms, novel chemical structures, and chemical property space. Finally, therapeutic strategies and the present use of marine-derived components, its future direction and limitations are discussed.


Related Papers

No related papers found

Powered by citation graph analysis